Migraine Treatment

Botox® Injection Therapy for Chronic Migraine

Woman in pink jacket holds her temples against pink backdrop, symbolic image for Migraine Treatment at BONITAS in Nuremberg

Chronic migraine is more than “just a headache”. It is debilitating, isolating, exhausting. It takes away your days. Quality of life. Freedom. And often it is resistant to pills, injections, or alternative methods.

The good news: Botox® is an officially approved migraine therapy – scientifically proven, gentle in application, and often highly effective. At BONITAS we perform the treatment with precision and personal care – for everyone who wants to reclaim a life free from pain

At a glance: Chronic migraine can be significantly reduced with Botox following the PREEMPT protocol (a medically indicated treatment).

  • Treatment time: 20–30 minutes
  • Method: botulinum toxin following the PREEMPT protocol (31 points)
  • Indication: chronic migraine (>15 days/month)
  • Onset of effect: after 2–4 weeks
  • Duration of effect: 3 months, repeat treatment recommended
  • Prices: in our price overview

How does Botox® work for migraines?

Botulinum toxin (Botox®) blocks the release of pain messengers at the nerve endings. This leads to:

This means: fewer attacks, shorter duration, lower intensity – often from the first treatment.

Who is a candidate for migraine treatment with Botox®?

BONITAS checks in a detailed consultation whether you are medically suitable for Botox migraine treatment – and develops a clear treatment plan.

How the treatment at BONITAS works

The injection is performed with very fine needles – almost painless. BONITAS ensures a relaxed, calm atmosphere.

Effects & Results

First effects noticeable after 7–14 days, the full effect usually after 2–3 treatments.

Advantages over classic therapy

Botox®

Medications

Why BONITAS?

BONITAS combines medical knowledge with genuine care – for a result that you not only feel, but can finally live again.

Frequently asked questions (FAQ)

Costs vary depending on the practice and the number of injections. An up-to-date price list can be found here.

Yes – the effect of botulinum toxin lasts for approximately 12 weeks on average. To control migraines long-term, regular repetition of the treatment is necessary. Many patients report a significant reduction in headache days and noticeable relief in daily life after just 2 to 3 treatment cycles. In the long term, this can also significantly reduce the medication burden.

Yes – Botulinum toxin A (OnabotulinumtoxinA) was approved by the EU in 2011 for chronic migraines and often reduces the number of headache days.

Common options include acute medications (triptans, NSAIDs), prophylaxis (beta-blockers, anticonvulsants, CGRP antibodies), and Botox. Alternatives include biofeedback, muscle relaxants, neuromodulation (e.g., occipital nerve stimulation), or in individual cases, invasive procedures.

The “10-20 rule” states: If there are more than 10 migraine days per month and/or over 20 headache days per month, preventive therapy is recommended – for example, with botulinum toxin, CGRP antibodies, or prophylactic medication.

Smiling man with dark hair and beard in white coat against light background: Alejandro Marti, specialist in plastic and aesthetic surgery, BONITAS Nuremberg
Get your advice now

If you are considering medical aesthetic treatment, schedule your consultation for an honest assessment tailored to your needs.

Scientific References

  1. Dodick DW et al. „OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.“ Headache. 2010. PubMed PMID 20487038
  2. Lanteri-Minet M et al. „Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.“ Cephalalgia. 2022. PubMed PMID 36081276
  3. Ornello R et al. „Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.“ Pain and Therapy. 2021. PubMed PMID 33778933
  4. Frank F et al. „CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis.“ Cephalalgia. 2021. PubMed PMID 34130525

Medically reviewed and written by
Specialist in Plastic and Aesthetic Surgery 🇩🇪 🇪🇸 · Consulting surgeon
With more than 1,000 plastic and aesthetic treatments performed, both surgical and minimally invasive. Comes from a family with a long tradition in Plastic and Aesthetic Surgery.
Last reviewed: May 2026